Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer

BACKGROUND/AIM:  The purpose of this study was to compare efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) and gemcitabine-cisplatin as first-line therapy in patients with pancreatic cancer. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: KAYAHAN, Neslihan, KARACA, Mustafa, SATIŞ, Hasan, YAPAR, Dilek, ÖZET, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569782/
https://www.ncbi.nlm.nih.gov/pubmed/33315355
http://dx.doi.org/10.3906/sag-2009-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569782/
https://www.ncbi.nlm.nih.gov/pubmed/33315355
http://dx.doi.org/10.3906/sag-2009-115

Ejemplares similares